FridayOL

FridayOL

en-US

Lilly's Zepbound approved by FDA for sleep apnea treatment

2025-01-02

lifestyle

Lilly's Zepbound approved by FDA for sleep apnea treatment

The FDA has approved Lilly's Zepbound, a glp-1 agonist, for the treatment of sleep apnea, which affects 25 million Americans and is often treated with a CPAP machine, but is often declined due to its cumbersome nature. ...Read more

Recommendations